COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

CORSE, EMILY RANA,FREYTAG, OLIVIER,GERDES, CHRISTIAN,LE CLECH, MARINE,LEVITSKY, HYAM,OTT, MARION,STERN, MARTIN,WEI, XU

申请号：

SG11201701039P

公开号：

SG11201701039PA

申请日:

2015.08.11

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present invention relates to a pharmaceutical product for the treatment of a proliferative disease, comprising the combination of an antibody, or an antigen-binding portion thereof, that specifically binds to human CD40； and a PD-L1 antibody； and optionally a 3rd component which comprises as an active ingredient a cytokine inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/